University of Utah startups continue innovating and discovering solutions to today’s unmet needs. Here’s a roundup of some of the latest news out of these companies:
Atavistik Bio Strengthens Leadership Team with Appointment of Paul Bruno, Ph.D. as Chief Business Officer
Atavistik Bio, a biotechnology company discovering the next generation of precision allosteric therapeutics inspired by the body’s natural regulators, announced the appointment of Paul Bruno, Ph.D., as Chief Business Officer. Dr. Bruno will lead strategic execution of Atavistik Bio’s business and corporate development efforts as the company advances its portfolio of oncology-focused precision allosteric small molecule candidates toward the clinic and leverages its platform to address a broad spectrum of diseases.
Utah Innovation Fund Invests in Purgo Scientific
Utah Innovation Fund is pleased to announce its recent investment in Purgo Scientific, a De Novo biotech firm with a mission to revolutionize treatment of surgical site infections. The Salt Lake City-based startup is Utah Innovation Fund’s seventh investment to date out of its $30M state-backed fund.
NeoIslets: Innovation Challenge Winner at ADA Scientific Session
Researchers are one step closer to a cure for Type 1 diabetes as demonstrated by one winner of the “Innovation Challenge” award at this year’s American Diabetes Associations’ Scientific Meeting in Orlando, FL. The ADA’s Innovation Challenge is designed to further “transformative solutions for people living with diabetes, their families, and caregivers,” and SymbioCellTech, a Salt Lake City-based regenerative medicine company was one of only 3 winners honored with this award at this year’s meeting.
